Martin J. Gunthorpe

机构：Autifony Therapeutics (United Kingdom), Stevenage Bioscience Catalyst · ORCID：0000-0002-0216-1735

发表论文 55 篇 · 总被引 9042 次 · h-index 35

代表论文

• Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potential (2009 · British Journal of Pharmacology · 被引 386)
• The mechanism of action of retigabine (ezogabine), a first‐in‐class K + channel opener for the treatment of epilepsy (2012 · Epilepsia · 被引 324)
• Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway (2008 · Drug Discovery Today · 被引 221)
• Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms (2008 · Current Pharmaceutical Design · 被引 200)
• TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons (2008 · Neuroscience Letters · 被引 190)
• Targeting Gut T Cell Ca2+ Release-Activated Ca2+ Channels Inhibits T Cell Cytokine Production and T-Box Transcription Factor T-Bet in Inflammatory Bowel Disease (2009 · The Journal of Immunology · 被引 105)